↓ Read PDF
01 · ABSTRACT

Abstract

Background: Informed consent provides detailed information to the participants to make informed voluntary and rational decision to participate in a study. It is a communication tool between investigator and the subject to ensure that high research ethical standards are followed. This review paper assessed the level of participants’ understanding of the information given to them by researchers during the clinical research.

Methods: A review approach was used to achieve the study objective.

Results: The findings showed that the level of comprehension varied from study to study. There was a good comprehension in four domains; purpose, voluntariness, benefits and right to withdraw. Poor comprehensions were mostly in risks, side effects, and blinding. Higher level of education, repeated assessments of comprehension, time spent by the researcher explaining and clarifying the information influenced the comprehension.

Conclusion: The study findings point out that comprehension to informed consent is still a challenge that needs to be addressed during the field study. Once the consent is given it becomes a distant memory for most of the participants. This implies that proper tools and cut off points to determine participants’ comprehension need to be developed for standard assessment of such.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 10 No 11 (2023): NOVEMBER ISSUE, VOl. 10 ISsue 11
SectionReview Articles
Published28 November 2022
DOI10.18103/mra.v10i11.3300
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

DK

Dorothy Maxwell Kazembe

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia ; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Blantyre, Malawi

TM

Tigist Mesfin, M.D

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia; St.Peter Specialized Hospital, Addis Ababa, Ethiopia.

AA

Abigiya Abebe, M.D

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia; Department of medicine, St. Paul’s hospital, P.O. Box 1271, Addis Ababa, Ethiopia

SE

Saba Mehari Embaye

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia

EM

Esther Nthenya Muthoka

Addis Ababa UniversityCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia; Tororo General Hospital, Tororo Uganda

KU

Kedir Usmael, M.D

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia; Department Of Medicine, College of Medicine and Health Sciences, Dire Dawa University, P.O Box 1362, Dire Dawa, Ethiopia

MA

Mediha Ahmedin

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗